Follow
Isolda Casanova Rigat
Isolda Casanova Rigat
CIBER
Verified email at santpau.cat
Title
Cited by
Cited by
Year
K-ras Codon 12 Mutation Induces Higher Level of Resistance to Apoptosis and Predisposition to Anchorage-independent Growth Than Codon 13 Mutation or Proto …
S Guerrero, I Casanova, L Farré, A Mazo, G Capellà, R Mangues
Cancer research 60 (23), 6750-6756, 2000
3142000
Mouse models in oncogenesis and cancer therapy
MV Cespedes, I Casanova, M Parreño, R Mangues
Clinical and Translational Oncology 8, 318-329, 2006
2262006
uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
MA Pavón, I Arroyo-Solera, MV Céspedes, I Casanova, X León, ...
Oncotarget 7 (35), 57351, 2016
1542016
Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles
U Unzueta, MV Céspedes, N Ferrer-Miralles, I Casanova, J Cedano, ...
International journal of nanomedicine, 4533-4544, 2012
1162012
In Vivo Architectonic Stability of Fully de Novo Designed Protein-Only Nanoparticles
MV Céspedes, U Unzueta, W Tatkiewicz, A Sanchez-Chardi, ...
ACS nano 8 (5), 4166-4176, 2014
1012014
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12
MV Céspedes, FJ Sancho, S Guerrero, M Parreño, I Casanova, MA Pavón, ...
Carcinogenesis 27 (11), 2190-2200, 2006
862006
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival
MJ Moreno, R Bosch, R Dieguez‐Gonzalez, S Novelli, A Mozos, ...
The Journal of pathology 235 (3), 445-455, 2015
822015
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
MA Pavón, I Arroyo-Solera, M Téllez-Gabriel, X León, D Virós, M López, ...
Oncotarget 6 (30), 29016, 2015
802015
Selective depletion of metastatic stem cells as therapy for human colorectal cancer
MV Céspedes, U Unzueta, A Aviñó, A Gallardo, P Álamo, R Sala, ...
EMBO molecular medicine 10 (10), e8772, 2018
692018
Gated mesoporous silica nanoparticles using a double‐role circular peptide for the controlled and target‐preferential release of doxorubicin in CXCR4‐expresing lymphoma cells
C De La Torre, I Casanova, G Acosta, C Coll, MJ Moreno, F Albericio, ...
Advanced Functional Materials 25 (5), 687-695, 2015
692015
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
L Sánchez-García, N Serna, P Álamo, R Sala, MV Céspedes, M Roldan, ...
Journal of controlled release 274, 81-92, 2018
622018
Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas
I Casanova, M Parreno, L Farré, S Guerrero, MV Céspedes, MA Pavon, ...
International journal of cancer 118 (10), 2381-2389, 2006
522006
Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin
R Diaz, V Pallares, O Cano‐Garrido, N Serna, L Sánchez‐García, ...
Small 14 (26), 1800665, 2018
512018
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model
P Alamo, A Gallardo, F Di Nicolantonio, MA Pavón, I Casanova, M Trias, ...
The FASEB Journal 29 (2), 464-476, 2015
512015
Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer
MA Pavón, M Parreno, X León, FJ Sancho, MV Céspedes, I Casanova, ...
International journal of cancer 123 (5), 1068-1079, 2008
502008
Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice
S Guerrero, A Figueras, I Casanova, L Farré, B Lloveras, G Capellà, ...
The FASEB Journal 16 (12), 1642-1644, 2002
502002
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
S Body, A Esteve-Arenys, H Miloudi, C Recasens-Zorzo, G Tchakarska, ...
Scientific reports 7 (1), 13946, 2017
482017
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
V Pallarès, U Unzueta, A Falgàs, L Sánchez-García, N Serna, A Gallardo, ...
Journal of hematology & oncology 13, 1-19, 2020
472020
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models
MV Céspedes, U Unzueta, P Álamo, A Gallardo, R Sala, I Casanova, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (7), 1987-1996, 2016
432016
Artificial inclusion bodies for clinical development
JM Sánchez, H López‐Laguna, P Álamo, N Serna, A Sánchez‐Chardi, ...
Advanced science 7 (3), 1902420, 2020
422020
The system can't perform the operation now. Try again later.
Articles 1–20